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Abstract
Melanoma metastasizing to the lungs is common, but primary pulmonary or pleural melanoma
is extremely rare. We present an autopsy case of malignant melanoma of the pleura without
primary skin lesion in a 49-year-old man. A mass found in the right chest was diagnosed as
spindle cell sarcoma by antemortem fine-needle aspiration cytology. At autopsy, a yellow-white
tumor located primarily in the right visceral pleura (diagnosed as an amelanotic melanoma) was
found to have invaded into the right lung, right parietal pleura, and right diaphragm, and to have
metastasized into the left lung and visceral pleura, thyroid, and left adrenal gland. No primary site
was found. The tumor cells were positive for S100 and focally positive for HMB-45, but negative
for other markers. Immuno-histochemical examination for S100 and HMB-45 would thus appear
to be useful for the diagnosis of an amelanotic melanoma.
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Melanoma metastasizing to the lungs is common,  but primary pulmonary or pleural melanoma is 
extremely rare.  We present an autopsy case of malignant melanoma of the pleura without primary 
skin lesion in a 49-year-old man.  A mass found in the right chest was diagnosed as spindle cell sar-
coma by antemortem ﬁne-needle aspiration cytology.  At autopsy,  a yellow-white tumor located pri-
marily in the right visceral pleura (diagnosed as an amelanotic melanoma) was found to have invaded 
into the right lung,  right parietal pleura,  and right diaphragm,  and to have metastasized into the left 
lung and visceral pleura,  thyroid,  and left adrenal gland.  No primary site was found.  The tumor cells 
were positive for S100 and focally positive for HMB-45,  but negative for other markers.  Immuno-
histochemical examination for S100 and HMB-45 would thus appear to be useful for the diagnosis of an 
amelanotic melanoma.
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alignant melanoma metastasizing to the lungs is 
common,  but malignant melanoma has very 
rarely been described as a primary tumor in the lower 
respiratory tract.  Moreover,  primary pleural mela-
noma is so rare that the available English-language 
literature on pleural malignant melanoma contains only 
one case of such a primary tumor [1] and no case with 
an amelanotic melanoma of the pleura.  We present 
here an autopsy case of malignant amelanotic mela-
noma of the pleura without primary skin lesion in a 
49-year-old man.  We discuss the histologic,  immuno-
histochemical,  and electron microscopic ﬁndings,  and 
we present evidence favoring immunohistochemistry 
for S-100 and HMB-45 as a useful tool in the diagno-
sis of an amelanotic melanoma.
Case Report
　 Some 2.5 months before he died,  a 49-year-old 
man was admitted to the hospital for cough,  right back 
pain,  and right pleural eﬀusion.  He had a history of 
miliary tuberculosis at 1 month after birth.  He had a 
29 pack-year history of smoking.  His past history was 
not exceptional,  apart from the above.
　 On admission,  a physical examination revealed a 
thumb-sized elastic,  hard,  subcutaneous mass in the 
right chest.  Upon laboratory examination,  WBC was 
increased (11.6×103/ml),  and CRP was slightly 
increased (1.99mg/ml).  Among biologic tumor mark-
ers,  neuron-speciﬁc enolase (NSE) was increased 
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(83ng/ml; normal＜10ng/ml).  The pleural eﬀusion 
was bloody,  the most common leukocytes were neutro-
philic ones,  and the mass was diagnosed as benign by 
cytological examination.  Chest X-ray on admission 
showed a large amount of right pleural eﬀusion and a 
left shift of the mediastinal shadow (Fig.  1A).  After 
drainage of the pleural eﬀusion,  chest computed 
tomography (CT) showed pleural thickening protrud-
ing like a nodular mass from the right thoracic wall 
(Fig.  1B).  However,  there was no abnormal ﬁnding in 
the left lung or in the whole-body scan (including the 
adrenal glands and brain).  Clinically,  pleural meso-
thelioma,  cancerous pleuritis,  or tuberculous pleuritis 
was suspected,  but adenosine diaminase (ADA) 
(3.5IU/l) and hyaluronic acid (83.3ng/l) in the pleural 
eﬀusion were within normal limits,  and an acid-fast 
bacteria stain was negative.  From ﬁne needle aspira-
tion cytology,  the subcutaneous right chest mass was 
diagnosed as suggestive of spindle cell sarcoma (Fig.  
2B).  The clinician was unable to make a deﬁnite 
diagnosis,  and the patient died about 2.5 months after 
admission due to respiratory failure.
Materials and Methods
　 Autopsy (except of the brain) was performed,  and 
all tissues were ﬁxed in 4ｵ formalin,  routinely pro-
cessed,  and stained with hematoxylin and eosin.
　 Immunohistochemistry was performed on de-paraf-
ﬁnized sections by the polymer-peroxidase method 
(EnVision＋/HRP; Dako Cytomation,  Glostrup,  
Denmark) using commercially available monoclonal 
antibodies against CAM 5.2 (Becton-Dickinson,  Moun-
tain View,  CA,  USA; ready-to-use),  cytokeratin 5/6 
(D5 & 16B4C; Cell Marque,  Greenwood,  AR,  USA;  
diluted 1 : 100),  cytokeratin 7 (OV-TL; 12/30;  
Zymed Laboratory,  South San Francisco,  CA,  USA;  
ready-to-use),  CK20 (Ks20.8; Nichirei,  Tokyo,  Japan;  
ready-to-use),  EMA (E29; Dako; diluted 1 : 50),  
TTF-1 (8G7G3/1; Dako; diluted 1 : 200),  α-smooth 
muscle actin (1A4; Dako; diluted 1: 200),  desmin 
(D33; Nichirei; ready-to-use),  CD31 (PECAM-1;  
Nvocastra,  Newcastle Upon Tyne,  UK; diluted 
1 : 50),  CD34 (NU-4A1; Nichirei; diluted 1 : 50),  
LCA (2B11; Nichirei; diluted 1 : 100),  HMB45 
(Dako; diluted 1 : 50),  and CD117 (Nichirei; ready-
to-use) as well as polyclonal antibodies against calreti-
nin (Chemicon,  Hot Springs,  AR,  USA; diluted 
1 : 800),  HHF35 (Dako; diluted 1 : 50),  and S-100 
(Dako; diluted 1 : 400).  For CD31 expression,  sec-
tions received autoclave pretreatment with 0.05M 
citrate buﬀer,  pH6.0,  for 20min.  For TTF-1 expres-
sion,  sections were boiled in 0.01mol/L Tris buﬀer 
containing 1mM/L EDTA,  pH9.0,  for 60min.
　 For electron-microscopic examination,  formalin-
ﬁxed specimens were ﬁrst rinsed with phosphate-buf-
fer,  then transferred to 2ｵ phosphate-buﬀered glu-
taraldehyde,  postﬁxed in 1ｵ osmium tetroxide,  and 
embedded in epoxy resin.  Ultrathin sections were cut 
and double-stained with uranyl acetate and lead cit-
rate.
　 For the molecular detection of EWSR1-ATF1 or 
EWSR1-CREB1 (for the diﬀerential diagnosis of 
clear cell sarcoma),  reverse transcription-polymerase 
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Fig. 1　 Chest x-ray and computed tomography (CT).  A,  Chest x-ray on admission showed a large amount of right pleural eﬀusion and a 
left shift of the mediastinal shadow; B,  After drainage of the pleural eﬀusion,  a chest CT showed pleural thickening protruding like a 
nodular mass from the right thoracic wall (arrows),  but no abnormal shadow in the right lung.
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Fig. 2　 Pathologic ﬁndings.  A,  Macroscopy showed a yellow-white tumor primarily located in the right visceral pleura; B,  Fine-needle 
aspiration cytology obtained from the subcutaneous right chest mass revealed numerous cohesive and thick clusters of cells with a high 
nuclear/cytoplasmic ratio,  oval nuclei,  and slightly increased chromatin content; C,  In autopsy specimens,  the predominantly spindle-cell 
foci exhibited a fascicular growth pattern with elongated-to-ovoid pleomorphic cells possessing large hyperchromatic nuclei and vague 
nucleoli; D,  Some ﬁnely granular brown pigment was present within both tumor cells and macrophages; E,  The pigment was positive by 
Fontana-Masson staining; F,  G,  By immunohistochemistry,  the tumor cells displayed a positive reaction for S100 (F),  and were focally 
positive for HMB-45 (G,  H) Electron microscopy revealed some vaguely lamellar or striated internal vesicles,  suggestive of aberrant mel-
anosomes.  Scale bars: (A) 3cm,  (B,  C,  D,  E, F and G) 100µm,  and (H) 1µm.
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chain reaction (RT-PCR) was performed using forma-
lin-ﬁxed,  paraﬃn-embedded tumor tissues,  as previ-
ously described [2].  Brieﬂy,  total RNA was 
extracted from the formalin-ﬁxed,  paraﬃn-embedded 
tissues using ISOGEN (Nippon Gene,  Tokyo,  Japan) 
followed by protein digestion with proteinase K 
(0.1mg/ml cell lysis solution) at 55°C overnight.  
RT-PCR was performed using an ampliﬁcation reagent 
kit (TaqMan EZRT-PCR kit; Applied Biosystems,  
Alameda,  CA,  USA) employing several primers.  The 
following primers were synthesized using an automated 
DNA synthesizer: EWSR1-exon 7 forward,  EWSR1-
exon 8 forward,  EWSR1-exon 9 forward,  ATF1-
exon 4 reverse,  ATF1-exon 5 reverse,  ATF1-exon 7 
reverse,  CREB1-exon 7 reverse,  and GAPDH.  
Sequence information for all the PCR primers used is 
listed in Table 1.  The reaction master mix was pre-
pared according to the manufacturerʼs protocol.  To 
perform PCR,  the RT reaction was incubated at 60°C 
for 30min,  followed by incubation at 95°C for 5min 
to deactivate AmpErase UNG.  The PCR was per-
formed using an ABI PRISM 7700 Sequence detector 
(Applied Biosystems) for 40 ampliﬁcation cycles at 
95°C for 20 sec and 60°C for 1min.  PCR products 
were separated by electrophoresis in a 3ｵ agarose gel 
and stained with ethidium bromide.
Results
　 Autopsy showed that a yellow-white tumor primar-
ily located in the right visceral pleura had invaded into 
the right lung tissue,  and also into the right parietal 
pleura,  diaphragm,  and thoracic wall,  connecting to a 
thumb-sized subcutaneous mass.  Also evident was 
extensive blood vessel metastasis involving the left 
lung and visceral pleura,  thyroid,  and left adrenal 
gland.  No primary site was found anywhere (including 
skin and other mucous membranes) (Fig.  2A).  
Histologically,  the predominantly spindle-cell foci 
exhibited a fascicular growth pattern with elongated-
to-ovoid pleomorphic cells possessing large hyper-
chromatic nuclei and vague nucleoli,  accompanied by 
areas of a nuclear palisading pattern and extensive 
necrosis (Fig.  2C).  Some nested and epithelioid foci 
were seen,  intermingled with cartilage-like diﬀeren-
tiation.  Some ﬁnely granular brown pigment was 
present within both tumor cells and macrophages (Fig.  
2D).  Most of this pigment was positive by Fontana-
Masson staining (Fig.  2E),  and it was bleached by 
potassium permanganate,  but negative by Prussian 
blue staining for iron.
　 Immunohistochemical analysis showed the tumor 
cells to be positive for S100 (Fig.  2F) and focally 
positive for HMB-45 (Fig.  2G),  but negative for other 
markers (keratin,  CAM 5.2,  CK5/6,  CK7,  CK20,  
EMA,  TTF-1,  calretinin,  α-smooth muscle actin,  
HHF35,  desmin,  CD31,  CD34,  CD117,  and LCA).  
Ultrastructurally,  the tumor cells were round or 
fusiform in shape with heterogeneous electron-dense 
areas.  Occasionally,  some showed a vaguely lamellar 
or striated internal structure or vesicles,  suggestive 
of aberrant melanosomes (Fig.  2H).  However,  we 
could not rule out melanin phagocytized by melano-
phages.  No neurosecretory granules were demon-
strated.  Based on the above,  we diagnosed an amelan-
otic melanoma of the right pleura.
　 No PCR product was found for the type 1 fusion 
transcript of EWSR1-ATF1 (EWRS1-exon 8 forward 
and ATF1-exon 4 reverse),  the type 2 fusion tran-
script of EWSR1-ATF1 (EWRS1-exon 7 forward and 
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Table 1　 Primer sequences used for reverse transcription-polymerase chain reaction (RT-PCR)
Primer Sequence
EWSR1-exon 7 forward 5ʼ-GCC AAG CTC CAA GTC AAT ATA GC
EWSR1-exon 8 forward 5ʼ-CAT GAG CAG AGG TGG GCG
EWSR1-exon 9 forward 5ʼ-AGA GCG AGG TGG CTT CAA TA
ATF1-exon 4 reverse 5ʼ-CCC CGT GTA TCT TCA GAA GAT AAG TC
ATF1-exon 5 reverse 5ʼ-CAA CTG TAA GGC TCC ATT TGG G
ATF1-exon 7 reverse 5ʼ-ACT CGG TTT TCC AGG CAT TT
CREB1-exon 7 reverse 5ʼ-GTA GTA CCC GGC TGA GTG GCT G
GAPDH forward 5ʼ-GAA GGT GAA GGT CGG AGT C
GAPDH reverse 5ʼ-GAA GAT GGT GAT GGG ATT TC
GAPDH,  glyceraldehyde-3-phosphate dehydrogenase.
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ATF1-exon 5 reverse),  the type 3 fusion transcript of 
EWSR1-ATF1 (EWRS1-exon 9 forward and ATF1-
exon 5 reverse),  the type 4 fusion transcript of 
EWSR1-ATF1 (EWRS1-exon 7 forward and ATF1-
exon 7 reverse),  or the fusion transcript of EWSR1-
CREB1 (EWRS1-exon 7 forward and CREB1-exon 7 
reverse),  although GAPDH was detected (Fig.  3).
Discussion
　 Malignant melanoma has very rarely been 
described as a primary tumor in the pleura or lower 
respiratory tract.  Indeed,  among cases of primary 
pleural melanoma,  only one case with malignant mela-
noma has been reported [1],  and all 8 cases of malig-
nant melanoma in the lower respiratory tract reported 
by Wilson & Moran presented as solitary,  central 
endobronchial neoplasms [3].  In contrast,  metastases 
of malignant melanoma to the lung or pleura are rela-
tively common.  It is therefore very important to dis-
tinguish primary from secondary melanomas.  Our case 
is suggestive of a primary lesion of the pleura since it 
satisﬁes the following criteria for a primary melanoma 
of organs in which melanocytes do not exist [3,  4]: i) 
a solitary tumor,  ii) a malignant melanoma conﬁrmed 
by immunohistochemistry and/or electron microscopy,  
iii) no history of previous cutaneous melanoma,  and iv) 
no demonstrable melanoma elsewhere at the time of 
diagnosis.  However,  it is known that primary cutane-
ous amelanotic melanoma may disappear during an 
advanced course [5].
　 It is well known that malignant altered melanocytes 
retain the ability to produce melanin,  yet a few cases 
of amelanotic melanomas have been reported.  Kato et 
al.  [6] reported that amelanotic melanomas were 
present in only 2 (1.3ｵ) of 150 cases with malignant 


















































































Fig. 3　 PCR products for EWSR1-ATF1,  EWSR1-CREB1,  and GAPDH.  No PCR product was found for the type 1 fusion transcript of 
EWSR1-ATF1 (EWRS1-exon 8 forward and ATF1-exon 4 reverse),  the type 2 fusion transcript of EWSR1-ATF1 (EWRS1-exon 7 forward 
and ATF1-exon 5 reverse),  the type 3 fusion transcript of EWSR1-ATF1 (EWRS1-exon 9 forward and ATF1-exon 5 reverse),  the type 4 
fusion transcript of EWSR1-ATF1 (EWRS1-exon 7 forward and ATF1-exon 7 reverse),  or the fusion transcript of EWSR1-CREB1 (EWRS1-
exon 7 forward and CREB1-exon 7 reverse),  although GAPDH was detected.
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melanomas diagnosed in Tohoku University Hospital 
between 1969 and 1990.  In the present case,  the 
tumor consisted,  histologically,  of predominantly 
spindle-cell foci with a fascicular growth pattern 
accompanied by areas of a nuclear palisading pattern.  
In our immunohistochemical examination,  tumor cells 
were negative for epithelial (keratin and EMA) and 
myogenic (desmin and α-smooth muscle actin) markers.  
However,  in some tumor cells we found ﬁnely granular 
brown pigments that exhibited a positive reaction to 
Fontana-Masson staining.  Furthermore,  tumor cells 
displayed a positive immunoreaction for melanocytic 
markers (S100 and HMB-45).  We therefore diagnosed 
an amelanotic melanoma of the right pleura.  To judge 
from the above ﬁndings,  an immunohistochemical 
examination for S-100 and HMB-45,  together with 
Fontana-Masson staining,  is a useful tool for the 
diagnosis of an amelanotic melanoma.
　 Two important diﬀerential diagnoses should be 
mentioned in the present case: one is pleural mesothe-
lioma,  the other is clear cell sarcoma.  The gross 
appearance in the present case showed a mass within 
and around the right visceral pleura,  similar to the 
masses seen in pleural mesothelioma (Fig.  2A).  
However,  no staining was found for imunohistochemi-
cal markers such as keratin,  CAM 5.2,  CK5/6,  CK7,  
CK20,  EMA,  or calretinin.  The latter tumor,  clear 
cell sarcoma,  is a malignant soft tissue tumor with 
melanocytic diﬀerentiation.  Even if such a tumor is 
not detected,  CD117 immunoreactivity,  recurrent 
chromosomal translocation t (12 ; 22) (q13 ; q12),  or a 
resultant fusion of the EWSR1 gene on 22q12 and the 
ATF1 gene on 12q13 is speciﬁcally detected in most 
cases of clear cell sarcoma [2].  Furthermore,  
another variant fusion gene,  EWSR1-CREB1,  has 
been found in a patient with clear cell sarcoma [2].  
Therefore,  fusion gene transcripts of either EWSR1-
ATF1 or EWSR1-CREB1 are detected.  In our case,  
however,  no CD117 immunoreactivity or EWSR1-
ATF1 or EWSR1-CREB1 fusion gene transcripts 
were detected.
　 The histogenesis of malignant melanoma of the 
pleura is unclear.  One explanation might be that 
cutaneous nevus cells enter dermal lymphatic vessels,  
and then travel via the lymphatic system to the pleura.  
In fact,  Biddle et al.  reported that nevus-cell aggre-
gates originating from the skin can reach the lymph 
nodes via the lymphatic system [7].  If nevus cells can 
migrate to the pleura in a similar way,  they could be 
the source of malignant melanoma.  However,  we know 
of no report of nevus-cell migration to the pleura,  so 
this idea must remain speculative.
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